Ana de Barros, PhD,  —

Ana holds a PhD in Immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. She graduated with a BSc in Genetics from the University of Newcastle and received a Masters in Biomolecular Archaeology from the University of Manchester, England. After leaving the lab to pursue a career in Science Communication, she served as the Director of Science Communication at iMM.

Articles by Ana de Barros

Burke, Blythedale Form N.Y. Partnership to Treat Children with CP, Other Neurological Diseases

A new partnership between two upstate New York entities will translate advances in neuroscience into improved treatments for children with cerebral palsy and other neurological diseases. The Burke Medical Research Institute (BMRI) in White Plains and Blythedale Children’s Hospital in Valhalla have launched the Burke-Blythedale Pediatric Neuroscience Research Collaboration — the first…

Horseback Riding Has Therapeutic Effects on People with Disabilities, Study Shows

Horseback riding can improve motor function and balance in people with cerebral palsy (CP) and other disabilities, says a new study. The study, “Therapeutic Effects of Horseback Riding Interventions: A Systematic Review and Meta-analysis,” appeared in the American Journal of Physical Medicine & Rehabilitation. It suggests that activities and therapies involving horses have a positive…

Egg Weights: A Promising Muscle Degenerative Therapy for Cerebral Palsy?

Walking or running with Egg Weights — an ergonomic system for endurance and resistance training that works with the body’s natural motion — may offer a promising muscle degenerative therapy for patients with cerebral palsy. The findings were reported by Egg Weights, a fitness and sports equipment company based in Thousand Oaks, California, following a…

PathMaker, French Medical Institute to Team Up to Test Device to Manage Palsy

PathMaker Neurosystems will team up with the Brain and Spine Institute in Paris on clinical trials of a device to help those with neuromotor spasticity, including cerebral palsy (CP) patients, manage their shaking and other symptoms. PathMaker’s goal is to obtain European Union approval of the company’s MyoRegulator, the first neuromodulation device designed…